This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

Early Bird pricing expires in:

  • 00
  • 00
  • 00
  • 00
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital

Elypta AB



Elypta is commercializing the world's first pan-cancer liquid biopsy platform based on metabolism. Exceptional sensitivity in all stages of cancer enables applications from screening to follow-up and response monitoring. The first application is early detection of recurring renal cell carcinoma with other urological cancers close behind.

Presenter: Karl Bergman, CEO, Elypta AB